'Mindfulness' stress reduction helps breast cancer survivors

March 20, 2012
'Mindfulness' stress reduction helps breast cancer survivors

(HealthDay) -- A mindfulness-based stress reduction (MBSR) program provides significant and lasting improvements in mood, breast- and endocrine-related quality of life, and well-being, according to research published online March 19 in the Journal of Clinical Oncology.

In an effort to compare the effects of an eight-week MBSR program with standard care on mood, breast- and endocrine-specific quality of life, and well-being, Caroline J. Hoffman, Ph.D., of The Haven in London, and colleagues conducted a involving 229 women with stage 0 to III who had undergone surgery, chemotherapy, and radiotherapy treatments.

The participants were evaluated using the Prolife of Mood States total mood disturbance and its subscales; Functional Assessment of Cancer Therapy-Breast; Functional Assessment of Cancer Therapy-Endocrine Symptoms; and the five-item well-being questionnaire. The researchers found that, at eight and 12 weeks, compared with standard care, women in the MBSR group experienced mostly statistically significant improvements in mood, breast- and endocrine-related quality of life, and well-being.

"To our knowledge, this study was the largest adequately powered trial to date that tested the effects of the MBSR program in women with stage 0 to III breast cancer," the authors write. "Important findings from this study included statistically significant improvements after MBSR compared with those of controls in overall mood, anxiety, depression, anger, vigor, fatigue, and confusion; breast- and endocrine-related quality of life; emotional, physical, social, and role functional well-being; and general well-being."

Explore further: Chemotherapy reduces breast cancer deaths by a third

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Chemotherapy reduces breast cancer deaths by a third

December 6, 2011

(Medical Xpress) -- Today’s chemotherapy treatments reduce deaths from breast cancer by around a third in a wide range of patients, a giant new analysis of data from over 100 different clinical trials has shown.

Recommended for you

Study: Colonoscopy after 75 may not be worth it

September 26, 2016

(HealthDay)—A colonoscopy can find and remove cancerous growths in the colon, but it may not provide much cancer prevention benefit after the age of 75, a new study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.